Founded in 1996 by Rick Lane, Amicus, Inc. is an application service provider of compliance technology solutions to securities broker-dealers and investment advisors and is located in Austin, Texas.
Amicus Therapeutics Inc. is withdrawing its initial public offering due to market conditions, according to a filing with the Securities and Exchange Commission.
Amicus is a clinical-stage biopharmaceutical company focused on the discovery and development of small-molecule, orally administered drugs for the treatment of a range of human genetic diseases.
Amicus had planned to use most of the net proceeds from the IPO to fund clinical trial activities and preclinical research and development activities.
Amicus, Inc. is an application service provider of compliance technology solutions to securities broker-dealers and investment advisors.
Amicus, Inc. was founded in 1996 by Rick Lane, and is located in Austin, Texas, USA.
Amicus specializes in providing software that aids the financial sector in achieving full Compliance with federal regulations such as the USA PATRIOT Act act.
Feeds |
Contact